Ask a question. Get a source-grounded answer with citations.
Based on 10 verified sources covering Thailand:
TOKYO -- Japanese trading house Sumitomo Corp. is partnering with U.S. nuclear fusion startup Shine Technologies to enter the Asian cancer treatment field, using the American company's strengths in radioisotopes to secure profits while gaining a foot... [1]
บริษัทเบสท์ริน กรุ๊ป แถลงข่าวกรณีใบรีมาร์กการนำรถเมล์เอ็นจีวีออกจากท่าเรือแหลมฉบัง [2]
PharmaceuticalsJapan's Ono Pharma to buy U.S. drugmaker Deciphera for $2.4bn Company seeks new revenue as patent expirations loom on cash-cow product Ono Pharmaceutical's headquarters in Osaka, Japan. [3]
CEBU, Philippines -- Structure Therapeutics, a clinical-stage biopharmaceutical company backed by venture capital investors, including Sequoia Capital China, has filed to raise $100 million in an initial public offering in the U.S. [4]
Key View - Indonesia’s pharmaceutical market will continue to represent a high-growth opportunity for multinational drugmakers. - Bolstering domestic pharmaceutical production will bode well for Indonesia’s export potential. [5]
NEW YORK -- CROs, or Contract Research Organizations, are expanding as rising demand for new medicines spurs pharmaceutical companies to seek more cost-effective research and development. [6]
SHANGHAI -- Dizal Pharmaceutical, a joint venture between China's state-owned SDIC Fund Management, AstraZeneca and Zytz Partners, has announced the closing of a $100 million financing round led by Lilly Asia Ventures. [7]
TechnologyIndonesian teledoctor Halodoc gets $80m in new funding round Conglomerate Astra and Singapore's Temasek among first-time investors Indonesian health tech startup Halodoc has begun offering a platform helping patients book COVID-19 tests and... [8]
TOKYO -- Japanese trading house Sumitomo Corp. is partnering with U.S. nuclear fusion startup Shine Technologies to enter the Asian cancer treatment field, using the American company's strengths in radioisotopes to secure profits while gaining a foot
บริษัทเบสท์ริน กรุ๊ป แถลงข่าวกรณีใบรีมาร์กการนำรถเมล์เอ็นจีวีออกจากท่าเรือแหลมฉบัง
PharmaceuticalsJapan's Ono Pharma to buy U.S. drugmaker Deciphera for $2.4bn Company seeks new revenue as patent expirations loom on cash-cow product Ono Pharmaceutical's headquarters in Osaka, Japan.
CEBU, Philippines -- Structure Therapeutics, a clinical-stage biopharmaceutical company backed by venture capital investors, including Sequoia Capital China, has filed to raise $100 million in an initial public offering in the U.S.
Key View - Indonesia’s pharmaceutical market will continue to represent a high-growth opportunity for multinational drugmakers. - Bolstering domestic pharmaceutical production will bode well for Indonesia’s export potential.
NEW YORK -- CROs, or Contract Research Organizations, are expanding as rising demand for new medicines spurs pharmaceutical companies to seek more cost-effective research and development.
SHANGHAI -- Dizal Pharmaceutical, a joint venture between China's state-owned SDIC Fund Management, AstraZeneca and Zytz Partners, has announced the closing of a $100 million financing round led by Lilly Asia Ventures.
TechnologyIndonesian teledoctor Halodoc gets $80m in new funding round Conglomerate Astra and Singapore's Temasek among first-time investors Indonesian health tech startup Halodoc has begun offering a platform helping patients book COVID-19 tests and
JAKARTA -- Indonesian dental technology startup Rata is in advanced talks to raise a pre-Series A funding round, which is set to be backed by existing investor Alpha JWC Ventures, as well as other regional investors.
MUMBAI (NewsRise) -- Sun Pharmaceutical Industries agreed to buy smaller rival Pola Pharma in Japan, as Indian drugmakers seek to create a niche in markets outside the U.S.